Also known as: University of Osaka
Cell and Gene Therapy Catapult has established a Technology Advisory Board to support technology deployment across advanced therapies. The board will focus on data, manufacturing, testing and patient pathways.
A study from the University of Osaka identified the integrin αV–YAP–CTGF pathway linking chronic liver congestion to fibrosis. The findings point to a potential therapeutic target in congestion-related liver disease.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06441994 |
Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer |
ACTIVE_NOT_RECRUITING | PHASE1 |
